MBX Biosciences (MBX) Institutional Ownership $9.89 -0.65 (-6.17%) Closing price 01/17/2025 04:00 PM EasternExtended Trading$10.06 +0.17 (+1.72%) As of 09:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for MBX Biosciences (NYSE:MBX)Number ofInstitutional Buyers(last 12 months)15TotalInstitutional Inflows(last 12 months)$384.09MNumber ofInstitutional Sellers(last 12 months)0 Get MBX Insider Trade Alerts Want to know when executives and insiders are buying or selling MBX Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MBX Institutional Buying and Selling by Quarter MBX Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/27/2024Franklin Resources Inc.450,000$11.69M0.0%N/A1.347% 11/19/2024Barclays PLC16,400$426K0.0%N/A0.049% 11/18/2024Teachers Retirement System of The State of Kentucky26,708$694K0.0%N/A0.080% 11/16/2024Geode Capital Management LLC22,269$579K0.0%N/A0.067% 11/15/2024Frazier Life Sciences Management L.P.5,985,347$155.50M6.2%N/A17.909% 11/15/2024Barclays PLC16,400$426K0.0%N/A0.049% 11/15/2024Jane Street Group LLC26,570$690K0.0%N/A0.080% 11/15/2024Wellington Management Group LLP2,937,853$74.26M0.0%N/A8.791% 11/15/2024Soros Fund Management LLC30,000$779K0.0%N/A0.090% 11/15/2024RA Capital Management L.P.1,511,334$39.26M0.5%N/A4.522% 11/15/2024Point72 DIFC Ltd24,011$624K0.0%N/A0.072% 11/15/2024Point72 Asset Management L.P.15,600$405K0.0%N/A0.047% 11/15/2024Maven Securities LTD50,000$1.30M0.0%N/A0.150% 11/15/2024Point72 Asia Singapore Pte. Ltd.10,706$278K0.1%N/A0.032% 11/14/2024NEA Management Company LLC3,614,486$93.90M5.1%N/A10.816% 11/13/2024The Manufacturers Life Insurance Company46,194$1.20M0.0%N/A0.138% (Data available from 1/1/2016 forward) MBX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MBX shares? During the previous two years, 15 institutional investors and hedge funds held shares of MBX Biosciences. The most heavily invested institutionals were Frazier Life Sciences Management L.P. ($155.50M), NEA Management Company LLC ($93.90M), Wellington Management Group LLP ($74.26M), RA Capital Management L.P. ($39.26M), Franklin Resources Inc. ($11.69M), Maven Securities LTD ($1.30M), and The Manufacturers Life Insurance Company ($1.20M).Learn more on MBX's institutional investors. Which institutional investors have been buying MBX Biosciences stock? Of the 15 institutional investors that purchased MBX Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Frazier Life Sciences Management L.P. ($5.99M), NEA Management Company LLC ($3.61M), Wellington Management Group LLP ($2.94M), RA Capital Management L.P. ($1.51M), Franklin Resources Inc. ($450K), Maven Securities LTD ($50K), and The Manufacturers Life Insurance Company ($46.19K). How much institutional buying is happening at MBX Biosciences? Institutional investors have bought a total of 14,783,878 shares in the last 24 months. This purchase volume represents approximately $384.09M in transactions. Related Companies Galapagos Institutional Ownership Arcutis Biotherapeutics Institutional Ownership Indivior Institutional Ownership Akero Therapeutics Institutional Ownership Dyne Therapeutics Institutional Ownership Immunocore Institutional Ownership Evotec Institutional Ownership Travere Therapeutics Institutional Ownership Vir Biotechnology Institutional Ownership Structure Therapeutics Institutional Ownership This page (NYSE:MBX) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MBX Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MBX Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.